Literature DB >> 9367216

Sensitive and convenient high-performance liquid chromatographic method for the determination of mitomycin C in human plasma.

G Joseph1, W Biederbick, U Woschée, M Theisohn, W Klaus.   

Abstract

An improved high-performance liquid chromatographic assay for the cytostatic drug mitomycin C in plasma is presented. The principal steps are precipitation of plasma proteins with acetonitrile, lyophilization of the supernatant and reversed-phase chromatography on a Hypersil ODS 5 microm column with 0.01 M NaH2PO4 buffer (pH 6.5)-methanol (70:30, v/v) in isocratic mode. At a flow-rate of 1.3 ml/min a column pressure of 180-220 bar resulted. Porfiromycin served as internal standard. UV detection was performed at 365 nm. Quantitation limit based on a coefficient of variation <10% in intra- and inter-day assay was 5 microg/l mitomycin C, detection limit based on a signal-to-noise ratio of 3 was 1 microg/l. Recovery was 100% and linearity was shown for the whole range of concentration (1-500 microg/l). None of the five drugs used during chemoembolisation interfered with the assay in vitro. The assay meets the requirements for pharmacokinetic studies of mitomycin C in patients as regards sensitivity and ease of use.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367216     DOI: 10.1016/s0378-4347(97)00291-0

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  3 in total

1.  Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination.

Authors:  Clayton B'Hymer; Thomas Connor; Derek Stinson; Jack Pretty
Journal:  J Chromatogr Sci       Date:  2014-08-16       Impact factor: 1.618

2.  The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines.

Authors:  Roxan F C P A Helderman; Daan R Löke; Jan Verhoeff; Hans M Rodermond; Gregor G W van Bochove; Menno Boon; Sanne van Kesteren; Juan J Garcia Vallejo; H Petra Kok; Pieter J Tanis; Nicolaas A P Franken; Johannes Crezee; Arlene L Oei
Journal:  Cells       Date:  2020-07-25       Impact factor: 6.600

3.  Characterization of a Mesoporous Silica Nanoparticle Formulation Loaded with Mitomycin C Lipidic Prodrug (MLP) and In Vitro Comparison with a Clinical-Stage Liposomal Formulation of MLP.

Authors:  Miguel Manzano; Alberto Gabizón; María Vallet-Regí
Journal:  Pharmaceutics       Date:  2022-07-17       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.